CIK: 0001549738 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 10, 2023
Total Value ($000): $243,052 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ESTA | ESTABLISHMENT LABS HLDGS INC | 3,192,485 | $209,587 | 86.2% | $24.59 | +145.7% | COM | G31249108 |
| CPRX | CATALYST PHARMACEUTICALS INC | 563,392 | $10,479 | 4.3% | $15.40 | 0.0% | COM | 14888U101 |
| CELH | CELSIUS HLDGS INC | 86,038 | $8,951 | 3.7% | $32.00 | +1.9% | COM NEW | 15118V207 |
| NVO | NOVO-NORDISK A S | 44,500 | $6,023 | 2.5% | $135.34 | — | ADR | 670100205 |
| — | HORIZON THERAPEUTICS PUB L | 50,673 | $5,767 | 2.4% | $24.06 | — | SHS | G46188101 |
| IDR | IDAHO STRATEGIC RESOURCES | 217,151 | $1,238 | 0.5% | $9.04 | -38.0% | COM NEW | 645827205 |
| — | MEDICUS SCIENCES ACQUISITION | 100,000 | $1,007 | 0.4% | $9.65 | — | CL A SHS | G5960S108 |
| — | MEDICUS SCIENCES ACQUISITION | 11,110 | $1 | 0.0% | $0.99 | — | *W EXP 02/12/202 | G5960S124 |